Skip to content

NEI/FDA CDER Glaucoma Clinical Drug Trial Design and Endpoints Symposium

News Brief


March 13-14, 2008
Natcher Auditorium
National Institutes of Health
Bethesda, Maryland

The National Eye Institute (NEI) and the Food and Drug Administration (FDA) are sponsoring a symposium to consider new disease-relevant outcome measures appropriate for evaluating glaucoma therapies.

Last updated: July 24, 2019